Cargando…
Synthetic multiantigen MVA vaccine COH04S1 and variant-specific derivatives protect Syrian hamsters from SARS-CoV-2 Omicron subvariants
Emerging SARS-CoV-2 Omicron subvariants continue to disrupt COVID-19 vaccine efficacy through multiple immune mechanisms including neutralizing antibody evasion. We developed COH04S1, a synthetic modified vaccinia Ankara vector that co-expresses Wuhan-Hu-1-based spike and nucleocapsid antigens. COH0...
Autores principales: | Wussow, Felix, Kha, Mindy, Kim, Taehyun, Ly, Minh, Yll-Pico, Marcal, Kar, Swagata, Lewis, Mark G., Chiuppesi, Flavia, Diamond, Don J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018591/ https://www.ncbi.nlm.nih.gov/pubmed/36928589 http://dx.doi.org/10.1038/s41541-023-00640-y |
Ejemplares similares
-
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates
por: Chiuppesi, Flavia, et al.
Publicado: (2022) -
COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variants
por: Wussow, Felix, et al.
Publicado: (2022) -
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial
por: Chiuppesi, Flavia, et al.
Publicado: (2022) -
Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy
por: Chiuppesi, Flavia, et al.
Publicado: (2023) -
Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters
por: Machado, Rafael R. G., et al.
Publicado: (2023)